ProfileGDS4718 / 213925_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 61% 89% 62% 57% 56% 53% 59% 64% 58% 58% 64% 58% 57% 50% 63% 54% 58% 54% 61% 56% 60% 56% 60% 56% 58% 63% 67% 60% 59% 55% 67% 62% 58% 64% 55% 55% 58% 59% 91% 58% 57% 65% 54% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.104260
GSM549102patient 115, normal, homogenized [OPG study]6.1809361
GSM549104patient 119, normal, homogenized [OPG study]9.09289
GSM549108patient 138, normal, homogenized [OPG study]6.2609462
GSM549119patient 077, normal, homogenized [OPG study]5.9383957
GSM549133patient 032, cancer, homogenized [OPG study]5.8515156
GSM549139patient 042, cancer, homogenized [OPG study]5.6601653
GSM549099patient 107, normal, homogenized [OPG study]6.0781259
GSM549109patient 139, normal, homogenized [OPG study]6.3911564
GSM549110patient 046, normal, homogenized [OPG study]6.0143458
GSM549114patient 063, normal, homogenized [OPG study]5.9675358
GSM549122patient 082, normal, homogenized [OPG study]6.4542964
GSM549134patient 033, cancer, homogenized [OPG study]5.9413458
GSM549136patient 036, cancer, homogenized [OPG study]5.9129857
GSM549140patient 044, cancer, homogenized [OPG study]5.4853950
GSM549111patient 047, normal, homogenized [OPG study]6.3418563
GSM549113patient 057, normal, homogenized [OPG study]5.7352654
GSM549132patient 031, cancer, homogenized [OPG study]6.0156958
GSM549137patient 038, cancer, homogenized [OPG study]5.7396954
GSM549142patient 047, cancer, homogenized [OPG study]6.2638661
GSM549100patient 110, normal, homogenized [OPG study]5.8647156
GSM549107patient 135, normal, homogenized [OPG study]6.0960360
GSM549115patient 068, normal, homogenized [OPG study]5.8358856
GSM549116patient 072, normal, homogenized [OPG study]6.1427660
GSM549120patient 078, normal, homogenized [OPG study]5.8573556
GSM549131patient 030, cancer, homogenized [OPG study]5.9951858
GSM549118patient 074, normal, homogenized [OPG study]6.3247763
GSM549129patient 027, cancer, homogenized [OPG study]6.7097667
GSM549123patient 088, normal, homogenized [OPG study]6.1325360
GSM549124patient 006, cancer, homogenized [OPG study]6.0427959
GSM549126patient 015, cancer, homogenized [OPG study]5.7997855
GSM549128patient 025, cancer, homogenized [OPG study]6.7013467
GSM549103patient 117, normal, homogenized [OPG study]6.2912962
GSM549117patient 073, normal, homogenized [OPG study]5.9251158
GSM549138patient 041, cancer, homogenized [OPG study]6.4287264
GSM549141patient 045, cancer, homogenized [OPG study]5.7700355
GSM549130patient 028, cancer, homogenized [OPG study]5.7870555
GSM549101patient 111, normal, homogenized [OPG study]5.9969458
GSM549105patient 128, normal, homogenized [OPG study]6.0541959
GSM549106patient 134, normal, homogenized [OPG study]9.4920191
GSM549112patient 048, normal, homogenized [OPG study]5.9926258
GSM549125patient 011, cancer, homogenized [OPG study]5.9143957
GSM549127patient 024, cancer, homogenized [OPG study]6.5236365
GSM549135patient 035, cancer, homogenized [OPG study]5.7452654